AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders-Reference-Cited by-同舟云学术

AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders

Published:2024-01 Issue:1 Volume:166 Page:59-85
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Barnes Edward L.,Agrawal Manasi,Syal Gaurav,Ananthakrishnan Ashwin N.,Cohen Benjamin L.,Haydek John P.,Al Kazzi Elie S.,Eisenstein Samuel,Hashash Jana G.,Sultan Shahnaz S.,Raffals Laura E.,Singh Siddharth

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference97 articles.

1. Incidence, risk factors, and outcomes of pouchitis and pouch-related complications in patients with ulcerative colitis;Barnes;Clin Gastroenterol Hepatol,2021

2. Results at up to 30 years after ileal pouch-anal anastomosis for chronic ulcerative colitis;Lightner;Inflamm Bowel Dis,2017

4. Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis;Burr;Gut,2022

5. Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis;Lasa;Lancet Gastroenterol Hepatol,2022

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The “HERICIUM-UC” Two-Arm Multicentre Retrospective Study;Pharmaceutics;2024-08-28

2. Assessing the Value of Histology and Anatomic Segment Evaluation Among Patients Undergoing Pouchoscopy;Inflammatory Bowel Diseases;2024-08-07

3. Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch;Digestive Diseases and Sciences;2024-08-01

4. Antibiotic Use in the 12 Months Prior to Ileal Pouch-Anal Anastomosis Increases the Risk for Pouchitis;Clinical Gastroenterology and Hepatology;2024-08

5. Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch;Inflammatory Bowel Diseases;2024-07-22